Access cutting-edge breast cancer treatment through this clinical trial at a research site in Concord. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Concord at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard endocrine therapy in patients with ER+/HER2 - early breast cancer with intermediate or high risk for disease recurrence who completed definitive locoregional therapy (with or without chemotherapy) and standard adjuvant endocrine therapy (ET) for at least 2 years and up to 5 years. The planned duration of treatment in either arm of the study is 60 months.
Sponsor: AstraZeneca
Check if you qualify for this breast cancer clinical trial in Concord, CA
If you're searching for breast cancer treatment options in Concord, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Concord research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.